Ackman’s Pershing Square Not Backing Down from Herbalife Short

March 31, 2017   Stephen Taub

The activist sold Valeant but is keeping his other high-profile losing investment.

Now that Bill Ackman has unloaded his huge losing stake in Valeant Pharmaceuticals International, is he going to finally close out his losing, high-profile negative bet on Herbalife? After all, since his epic 3.5-hour, 334-slide public case for shorting the …


Subscribers have unlimited access to all online content inc rankings. Start your subscription today - click on the button below.

Subscribe now

Free trial

Taking a free trial will give you access to online content one week (excludes research & rankings). Start your trial today.

Free Trial

Latest Poll

How will hedge funds finish 2017?

 - 72%
 - 11%
 - 17%

View previous results